Design of novel benzylidenecyclohexenones derivatives as potential anti-cancer inhibitors using 3D-QSAR, pharmacokinetics, and molecular docking studies.

Mohammed Er-rajy(Euro-Mediterranean University of Fes), Menana Elhallaoui(Sidi Mohamed Ben Abdellah University), Sara Zarougui(Sidi Mohamed Ben Abdellah University), Nidal Naceiri Mrabti(Sidi Mohamed Ben Abdellah University)
Research Square
April 13, 2022
10.21203/rs.3.rs-1510373/v1
Cited by 3

Related Papers

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia
|Pharmaceuticals|2022|71
Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation
|Journal of Biomolecular Structure and Dynamics|2023|55
2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives
|Structural Chemistry|2022|54
3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists
|Processes|2022|53
QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties
|Heliyon|2023|46